SEARCH

SEARCH BY CITATION

References

  • Abu El-Asrar AM, Struyf S, Kangave D, Geboes K & Van Damme J (2006): Chemokines in proliferative diabetic retinopathy and proliferative vitreoretinopathy. Eur Cytokine Netw 17: 155165.
  • Aiello LP, Northrup JM, Keyt BA, Takagi H & Iwamoto MA (1995): Hypoxic regulation of vascular endothelial growth factor in retinal cells. Arch Ophthalmol 113: 15381544.
  • Cakir M, Dogan M, Bayraktar Z, Bayraktar S, Acar N, Altan T, Kapran Z & Yilmaz OF (2008): Efficacy of intravitreal triamcinolone for the treatment of macular edema secondary to branch retinal vein occlusion in eyes with or without grid laser photocoagulation. Retina 28: 465472.
  • Chen SD, Lochhead J, Patel CK & Frith P (2004): Intravitreal triamcinolone acetonide for ischaemic macular oedema caused by branch retinal vein occlusion. Br J Ophthalmol 88: 154155.
  • Fekrat DFaS (1999): Venous occlusive disease. In: Regillo CD, Brown GC & Flynn HW Jr (eds). Vitreoretinal disease. The essentials. New York, Stuttgart: Thieme 117132.
  • Frangogiannis NG (2004): Chemokines in the ischemic myocardium: from inflammation to fibrosis. Inflamm Res 53: 585595.
  • Funatsu H, Noma H, Mimura T, Eguchi S & Hori S (2009): Association of vitreous inflammatory factors with diabetic macular edema. Ophthalmology 116: 7379.
  • Funk M, Kriechbaum K, Prager F, Benesch T, Georgopoulos M, Zlabinger GJ & Schmidt-Erfurth U (2009): Intraocular concentrations of growth factors and cytokines in retinal vein occlusion and the effect of therapy with bevacizumab. Invest Ophthalmol Vis Sci 50: 10251032.
  • Gourmala NG, Limonta S, Bochelen D, Sauter A & Boddeke HW (1999): Localization of macrophage inflammatory protein: macrophage inflammatory protein-1 expression in rat brain after peripheral administration of lipopolysaccharide and focal cerebral ischemia. Neuroscience 88: 12551266.
  • Huber SA, Sakkinen P, Conze D, Hardin N & Tracy R (1999): Interleukin-6 exacerbates early atherosclerosis in mice. Arterioscler Thromb Vasc Biol 19: 23642367.
  • Inoue M, Nagai N, Shinoda H, Shinoda K, Kitamura S & Oguchi Y (2004): [Intravitreal injection of triamcinolone acetonide for cystoid macular edema resistant to vitreous surgery]. Nippon Ganka Gakkai Zasshi 108: 9297.
  • Jonas JB, Kreissig I, Kamppeter B & Degenring RF (2004): [Intravitreal triamcinolone acetonide for the treatment of intraocular edematous and neovascular diseases]. Ophthalmologe 101: 113120.
  • Kogure A, Ohkoshi K, Kogure S, Yamaguchi T & Kishi S (2008): Efficacy and retention times of intravitreal triamcinolone acetonide for macular edema. Jpn J Ophthalmol 52: 122126.
  • Lee WF & Yang CM (2004): Intravitreal triamcinolone injection for macular edema secondary to increased retinal vascular permeability. J Formos Med Assoc 103: 692700.
  • McAllister IL, Vijayasekaran S, Chen SD & Yu DY (2009): Effect of triamcinolone acetonide on vascular endothelial growth factor and occludin levels in branch retinal vein occlusion. Am J Ophthalmol 147: 838846.
  • Nakazawa T, Matsubara A, Noda K et al. (2006): Characterization of cytokine responses to retinal detachment in rats. Mol Vis 12: 867878.
  • Nakazawa T, Hisatomi T, Nakazawa C et al. (2007a): Monocyte chemoattractant protein 1 mediates retinal detachment-induced photoreceptor apoptosis. Proc Natl Acad Sci U S A 104: 24252430.
  • Nakazawa T, Takeda M, Lewis GP et al. (2007b): Attenuated glial reactions and photoreceptor degeneration after retinal detachment in mice deficient in glial fibrillary acidic protein and vimentin. Invest Ophthalmol Vis Sci 48: 27602768.
  • Noma H, Funatsu H, Yamasaki M et al. (2005): Pathogenesis of macular edema with branch retinal vein occlusion and intraocular levels of vascular endothelial growth factor and interleukin-6. Am J Ophthalmol 140: 256261.
  • Noma H, Minamoto A, Funatsu H, Tsukamoto H, Nakano K, Yamashita H & Mishima HK (2006): Intravitreal levels of vascular endothelial growth factor and interleukin-6 are correlated with macular edema in branch retinal vein occlusion. Graefes Arch Clin Exp Ophthalmol 244: 309315.
  • Noma H, Funatsu H, Yamasaki M et al. (2008): Aqueous humour levels of cytokines are correlated to vitreous levels and severity of macular oedema in branch retinal vein occlusion. Eye 22: 4248.
  • Noma H, Funatsu H, Sakata K, Mimura T & Hori S (2010): Macular microcirculation before and after vitrectomy for macular edema with branch retinal vein occlusion. Graefes Arch Clin Exp Ophthalmol 248: 443445.
  • Opremcak EM & Bruce RA (1999): Surgical decompression of branch retinal vein occlusion via arteriovenous crossing sheathotomy: a prospective review of 15 cases. Retina 19: 15.
  • Park SP & Ahn JK (2008): Changes of aqueous vascular endothelial growth factor and interleukin-6 after intravitreal triamcinolone for branch retinal vein occlusion. Clin Experiment Ophthalmol 36: 831835.
  • Pinderski LJ, Fischbein MP, Subbanagounder G et al. (2002): Overexpression of interleukin-10 by activated T lymphocytes inhibits atherosclerosis in LDL receptor-deficient Mice by altering lymphocyte and macrophage phenotypes. Circ Res 90: 10641071.
  • Rehak M, Hollborn M, Iandiev I et al. (2009): Retinal gene expression and Muller cell responses after branch retinal vein occlusion in the rat. Invest Ophthalmol Vis Sci 50: 23592367.
  • Roh MI, Kim HS, Song JH, Lim JB & Kwon OW (2009): Effect of intravitreal bevacizumab injection on aqueous humor cytokine levels in clinically significant macular edema. Ophthalmology 116: 8086.
  • Scott IU, VanVeldhuisen PC, Oden NL, Ip MS, Blodi BA, Jumper JM & Figueroa M (2009): SCORE Study report 1: baseline associations between central retinal thickness and visual acuity in patients with retinal vein occlusion. Ophthalmology 116: 504512.
  • Shimura M, Nakazawa T, Yasuda K, Kunikata H, Shiono T & Nishida K (2008): Visual prognosis and vitreous cytokine levels after arteriovenous sheathotomy in branch retinal vein occlusion associated with macular oedema. Acta Ophthalmol 86: 377384.
  • Silva RM, Faria de Abreu JR & Cunha-Vaz JG (1995): Blood-retina barrier in acute retinal branch vein occlusion. Graefes Arch Clin Exp Ophthalmol 233: 721726.
  • Struyf S, Proost P & Van Damme J (2003): Regulation of the immune response by the interaction of chemokines and proteases. Adv Immunol 81: 144.
  • Tachi N, Hashimoto Y & Ogino N (1999): Vitrectomy for macular edema combined with retinal vein occlusion. Doc Ophthalmol 97: 465469.
  • Tojo N, Kashiwagi Y, Nishitsuka K et al. (2009): Interactions between vitreous-derived cells and vascular endothelial cells in vitreoretinal diseases. Acta Ophthalmol: Epub ahead of print.
  • Uckermann O, Kutzera F, Wolf A, Pannicke T, Reichenbach A, Wiedemann P, Wolf S & Bringmann A (2005): The glucocorticoid triamcinolone acetonide inhibits osmotic swelling of retinal glial cells via stimulation of endogenous adenosine signaling. J Pharmacol Exp Ther 315: 10361045.
  • Vasconcelos-Santos DV, Nehemy PG, Schachat AP & Nehemy MB (2008): Secondary ocular hypertension after intravitreal injection of 4 mg of triamcinolone acetonide: incidence and risk factors. Retina 28: 573580.
  • Whitman SC, Ravisankar P, Elam H & Daugherty A (2000): Exogenous interferon-gamma enhances atherosclerosis in apolipoprotein E-/- mice. Am J Pathol 157: 18191824.
  • Yoshida S, Yoshida A, Ishibashi T, Elner SG & Elner VM (2003): Role of MCP-1 and MIP-1alpha in retinal neovascularization during postischemic inflammation in a mouse model of retinal neovascularization. J Leukoc Biol 73: 137144.
  • Zeng HY, Zhu XA, Zhang C, Yang LP, Wu LM & Tso MO (2005): Identification of sequential events and factors associated with microglial activation, migration, and cytotoxicity in retinal degeneration in rd mice. Invest Ophthalmol Vis Sci 46: 29922999.